Clinical Risk Returns

Investors reassess the quality, durability, or regulatory path of Silence's most important RNAi programs before closing. The cash offer still provides support, but the market assigns a higher probability of delay, renegotiation, or post-close write-downs.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.